核酸
重组酶聚合酶扩增
核酸外切酶
核糖核酸
聚合酶
DNA
化学
Cas9
寡核苷酸
分子生物学
生物
计算生物学
分子信标
清脆的
生物化学
重组酶
RNA定向DNA聚合酶
核苷酸
脱氧核酶
自催化
劈理(地质)
逆转录酶
核酸外切酶 III
滚动圆复制
聚合酶链反应
核酸法
DNA聚合酶
核酸热力学
RNA聚合酶Ⅲ
作者
Wenhao Yin,Hong Xu,Xiangang Xia,Yi Du,Xinping Wang,Ruyi He,Zhuo Chen,Jie Qiao,Yi Liu
标识
DOI:10.1038/s41467-026-79722-z
摘要
The CRISPR-Cas9 system exhibits limited trans-cleavage activity, restricting its utility for nucleic acid detection. Here, we present a split RNA-guided Cas9 system (SCas9) that overcomes this limitation. By partitioning single-guide RNA into functionally independent scaffold and spacer modules, SCas9 enables amplification-free detection of single-stranded DNA and RNA with picomolar sensitivity within 30 min and single-nucleotide specificity. Incorporation of λ exonuclease permits PAM-independent detection of double-stranded DNA without cis-cleavage activity. Coupling SCas9 with recombinase polymerase amplification or reverse transcription–recombinase polymerase amplification extends detection of double-stranded DNA and long RNA to attomolar sensitivity. We further developed an autocatalytic SCas9 strategy for attomolar microRNA detection. SCas9 demonstrates broad substrate compatibility and was validated in clinical specimens, including human papillomavirus 16 in vaginal secretions and miR-21 in colorectal cancer tissues, highlighting its potential for point-of-care diagnostics. CRISPR-Cas9 lacks collateral cleavage for nucleic acid diagnostics. Here, authors show that splitting the guide RNA into scaffold and spacer converts Cas9 into SCas9, enabling rapid, single-nucleotide-specific DNA/RNA sensing, PAM-independent dsDNA detection, and attomolar clinical assays.
科研通智能强力驱动
Strongly Powered by AbleSci AI